检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

First-line treatment with sintilimab (sin) vs placebo in combination with chemotherapy (chemo) in patients (pts) with unresectable gastric or gastroesophageal junction (G/GEJ) cancer: Final overall survival (OS) results from the randomized, phase III ORIENT-16 trial

Jianming Xu,Haiping Jiang,Yueyin Pan,Kangsheng Gu,Shundong Cang, Lei Han,Yongqian Shu,Jiayi Li,Junhui Zhao,Hongming Pan,Suxia Luo,Yanru Qin, Qunyi Guo,Yuxian Bai,Yang Ling, Yingmei Guo,Yuling Chen,Yan Wang, Hui Zhou

CANCER RESEARCH（2023）

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要